No. 24-1302

MSP Recovery Claims, Series LLC, a Delaware Series Limited Liability Company, et al. v. Lundbeck LLC, a Delaware Corporation, et al.

Lower Court: Fourth Circuit
Docketed: 2025-06-26
Status: Denied
Type: Paid
Response RequestedResponse WaivedRelisted (2)
Tags: civil-rico drug-manufacturer foreseeability prescribing-decisions proximate-cause rico-statute
Key Terms:
SocialSecurity Antitrust Securities JusticiabilityDoctri ClassAction
Latest Conference: 2025-11-21 (distributed 2 times)
Question Presented (AI Summary)

Whether physicians' prescribing decisions constitute an intervening cause in a civil RICO action against a drug manufacturer for overpayment of drugs, and whether the RICO injury of a primary victim is a direct result when it is the natural and foreseeable consequence of a fraudulent scheme

Question Presented (OCR Extract)

The Racketeer Influenced & Corrupt Organizations Act (“RICO ”) provides a private cause of action to “[a]ny person injured in his business or property by reason of a violation of ” 18 U.S.C. § 1962 . 18 U.S.C. § 1964. This Court has long held “by reason of” requires a showing of proximate caus e. Holmes v. Sec. Inv. Prot. Corp. , 503 U.S. 258 , 268 (1992) . In civil RICO actions against drug manufacturers for overpayment of drugs , a circuit split has developed over whether physicians ’ prescribing decision s defeat proximate cause. Three circuits have concluded that a physician’s decision do es not defeat proximate cause. Two circuits have concluded the opposite . Below , the Fourth Circuit joined the minority vie w. Additionally , the courts of appeals are fractured over whether , in the RICO proximate cause analysis, the foreseeability can support the directness of a RICO injury . Five circuits have held that foreseeability is part of proximate cause. One circuit has held that foreseeability has no bearing on proximate caus e at all . Four circuit s have adopted conflicting holding s, including the Fourth Circuit . The question s presented are: (1) Whether , in a civil RICO action against a drug manufacturer for overpayment of drugs , physicians ’ prescribing decision s constitute an intervening cause . (2) Whether the RICO injury of a primary and intended victim is a direct result of a scheme to defraud when it is the natural and foreseeable consequences of such scheme .

Docket Entries

2025-11-24
Petition DENIED.
2025-11-05
DISTRIBUTED for Conference of 11/21/2025.
2025-11-03
Reply of MSP Recovery Claims, Series LLC,, et al. submitted.
2025-11-03
Reply of petitioners MSP Recovery Claims, Series LLC, et al. filed. (Distributed)
2025-10-20
Brief of Lundbeck LLC in opposition submitted.
2025-10-20
Brief of respondents Lundbeck LLC, et al. in opposition filed.
2025-09-02
Motion to extend the time to file a response is granted and the time is extended to and including October 20, 2025, for all respondents. See Rule 30.1.
2025-08-29
Motion of Lundbeck LLC for an extension of time submitted.
2025-08-29
Motion to extend the time to file a response from September 18, 2025 to October 18, 2025, submitted to The Clerk.
2025-08-19
Response Requested. (Due September 18, 2025)
2025-08-06
DISTRIBUTED for Conference of 9/29/2025.
2025-07-08
Waiver of right of respondent TheraCom LLC to respond filed.
2025-07-03
Waiver of Lundbeck LLC of right to respond submitted.
2025-07-03
Waiver of right of respondent Lundbeck LLC to respond filed.
2025-06-23
Petition for a writ of certiorari filed. (Response due July 28, 2025)

Attorneys

Lundbeck LLC
Kolya David GlickArnold & Porter Kaye Scholer LLP, Respondent
MSP Recovery Claims, Series LLC,, et al.
Shereef Hadi AkeelAkeel & Valentine, PLC, Petitioner
TheraCom LLC
Thomas Howle Suddath Jr.Reed Smith LLP, Respondent